Myriota expands IoT reach into Canada

Nanosatellite developer Myriota has extended its reach in the Canadian market with the purchase of satellite communications assets from exactEarth Ltd. The acquisition will see Myriota Canada acquire four satellites, a global network of ground station assets, and their associated spectrum licenses. The acquisition will increase the Adelaide company’s capability to deliver low-cost, low-power, secure…

CSIRO begins testing Covid-19 vaccines as part of global effort

By Peter Roberts In an exciting development Australia’s CSIRO has begun testing potential vaccines against the Covid-19 coronavirus at its Australian Animal Health Laboratory (AAHL) facility in Geelong. Testing in the biosecure facility originally built to contain the world’s most harmful plant and animal diseases is part of a global effort led by the interational Coalition…

Launch of 2020 media kit, an introduction, and a special offer from @AuManufacturing

@AuManufacturing news is pleased to announce the launch of our 2020 media kit – the first major revision to our offering to advertisers since our launch in November, 2018. The kit features prices for website and newsletter advertising, introduces the new Technology section of our website, and launches our second weekly newsletter. The new features…

Noxopharm investigates Covid-19 treatment

Drug developer Noxopharm is following up on indications that an experimental anti-cancer drug may be effective against the Covid-19 coronavirus. Melbourne’s Hudson Institute of Medical Research has identified anti-inflammatory properties of the experimental drug idronoxil, the active ingredient in the company’s anti-cancer drug candidate Veyonda. Pre-clinical models indicate the drug has the ability to treat…